Cargando…

Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib

A tyrosine kinase inhibitor, vandetanib (Van), is an anticancer drug affecting the signaling of VEGFR, EGFR and RET protooncogenes. Van is primarily used for the treatment of advanced or metastatic medullary thyroid cancer; however, its usage is significantly limited by side effects, particularly ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jáklová, Kateřina, Feglarová, Tereza, Rex, Simona, Heger, Zbyněk, Eckschlager, Tomáš, Hraběta, Jan, Hodek, Petr, Kolárik, Matúš, Indra, Radek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074211/ https://www.ncbi.nlm.nih.gov/pubmed/33923880 http://dx.doi.org/10.3390/ijms22084250

Ejemplares similares

Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation
por: Indra, Radek, et al.
Publicado: (2019)

Vandetanib
por: Vozniak, J. Michael, et al.
Publicado: (2012)

Apoferritin as an ubiquitous nanocarrier with excellent shelf life
por: Dostalova, Simona, et al.
Publicado: (2017)

Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System
por: Skubalova, Zuzana, et al.
Publicado: (2021)

Stevens-Johnson Syndrome Induced by Vandetanib
por: Yoon, Jimi, et al.
Publicado: (2011)

Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib
por: Znati, Sami, et al.
Publicado: (2020)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

Role of vandetanib in the management of medullary thyroid cancer
por: Brassard, Maryse, et al.
Publicado: (2012)

Selective use of vandetanib in the treatment of thyroid cancer
por: Fallahi, Poupak, et al.
Publicado: (2015)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
por: Cury-Martins, Jade, et al.
Publicado: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
por: Qadir, Abdul, et al.
Publicado: (2023)

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
por: Deshpande, Hari, et al.
Publicado: (2011)

MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT/NMYC Axis Induces Cell Death in NMYC Amplified Neuroblastoma Cell Lines
por: Feriancikova, Barbara, et al.
Publicado: (2021)

Photosensitivity Reactions to Vandetanib: Redevelopment after Sequential Treatment with Docetaxel
por: Son, Young-Min, et al.
Publicado: (2011)

Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole
por: Martin, Paul, et al.
Publicado: (2012)

Long‐term cardiovascular effects of vandetanib and pazopanib in normotensive rats
por: Cooper, Samantha L., et al.
Publicado: (2019)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis()
por: Gul, Busra Demirbag, et al.
Publicado: (2022)

Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
por: Deshpande, Hari, et al.
Publicado: (2011)

A secondary RET mutation in the activation loop conferring resistance to vandetanib
por: Nakaoku, Takashi, et al.
Publicado: (2018)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
por: Fallahi, Poupak, et al.
Publicado: (2019)

Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice
por: Puhl, Ana C., et al.
Publicado: (2021)

Vandetanib-Induced Hyponatremia and Torsades De Pointes: A Case Report
por: Ashraf, Shoaib, et al.
Publicado: (2022)

Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin
por: Dostalova, Simona, et al.
Publicado: (2018)

Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b(5) Activity
por: Indra, Radek, et al.
Publicado: (2020)

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
por: Grande, Enrique, et al.
Publicado: (2013)

A rare case of late-onset lichenoid photodermatitis after vandetanib therapy
por: Bota, James, et al.
Publicado: (2015)

MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib
por: Lassalle, Sandra, et al.
Publicado: (2016)

An alternative synthesis of Vandetanib (Caprelsa™) via a microwave accelerated Dimroth rearrangement
por: Brocklesby, Kayleigh L., et al.
Publicado: (2017)

Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
por: Puhl, Ana C., et al.
Publicado: (2022)

Vortex Keratopathy in a Patient Receiving Vandetanib for Non-Small Cell Lung Cancer
por: Ahn, Jeeyun, et al.
Publicado: (2011)

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
por: Flanigan, Jaclyn, et al.
Publicado: (2010)

Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy
por: Lodish, Maya, et al.
Publicado: (2015)

Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience
por: Kim, Mijin, et al.
Publicado: (2020)

Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer()
por: Bostan, Ecem, et al.
Publicado: (2022)

Nanomedicine of tyrosine kinase inhibitors
por: Smidova, Veronika, et al.
Publicado: (2021)

Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery
por: Blazkova, Iva, et al.
Publicado: (2013)

Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib
por: Andersson, Mattias K, et al.
Publicado: (2008)

A systematic review and meta-analysis of the risk of diarrhea associated with vandetanib treatment in carcinoma patients
por: Huo, Zijun, et al.
Publicado: (2016)

Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy
por: Colombo, Carla, et al.
Publicado: (2018)

Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia
por: Wei, Huiqiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gopftghqfr77ie8snan90srmq4